UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Osteoporosis in postmenopausal women living with HIV

Finnerty, F; Walker-Bone, K; Tariq, S; (2017) Osteoporosis in postmenopausal women living with HIV. Maturitas , 95 pp. 50-54. 10.1016/j.maturitas.2016.10.015. Green open access

[img]
Preview
Text (Accepted manuscript)
Finnerty_Osteoporosis in postmenopausal women living with HIV.pdf

Download (122kB) | Preview
[img]
Preview
Text (Figure 1)
Finnerty_Osteoporosis in postmenopausal women living with HIV - FIG 1.pdf

Download (35kB) | Preview
[img]
Preview
Text (Figure 2)
Finnerty_Osteoporosis in postmenopausal women living with HIV - FIG 2.pdf

Download (87kB) | Preview

Abstract

The widespread availability of effective antiretroviral therapy (ART) has transformed HIV from a life-limiting condition to one with near-normal life expectancy. HIV is associated with an increased risk of osteopenia and osteoporosis, with people living with HIV (PLHIV) potentially experiencing these conditions at a younger age than their HIV-negative counterparts. The mechanisms driving bone disease in HIV are complex and include: an increased prevalence of traditional risk factors; other comorbid conditions; and HIV-associated factors such as viral effects, systemic inflammation, and ART-related factors. One-third of PLHIV in the United Kingdom are female, and increasing numbers of women living with HIV (WLHIV) are reaching menopausal age. Oestrogen decline in the context of an elevated background risk of poor bone health results in WLHIV being at greater risk of osteoporosis than women without HIV. European HIV guidelines therefore recommend routine screening of postmenopausal WLHIV using FRAX(©) for clinical risk factors, with or without bone mineral density scanning. Data support the use of calcium and vitamin D supplementation, and bisphosphonates in the treatment of osteoporosis in PLHIV. Additionally, some patients with confirmed osteoporosis may benefit from a switch to an ART agent with a better bone safety profile. However, there remains a notable paucity of data on HIV and menopause, including the impact of hormone replacement therapy on the bone health of WLHIV. In conclusion, it is important that clinicians are aware that postmenopausal WLHIV are a group at particular risk of bone disease, who require proactive screening and advice about preventative measures.

Type: Article
Title: Osteoporosis in postmenopausal women living with HIV
Location: Ireland
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.maturitas.2016.10.015
Publisher version: http://dx.doi.org/10.1016/j.maturitas.2016.10.015
Language: English
Additional information: Copyright © 2016 Elsevier Ireland Ltd. All rights reserved. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Keywords: HIV, Menopause, Osteoporosis, Women
UCL classification: UCL
UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health > Infection and Population Health
URI: https://discovery.ucl.ac.uk/id/eprint/1530122
Downloads since deposit
69Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item